<2>Why IBD Stock Of The Day Harrow Has Its Sights On A Breakout
<3>The Bull Case For Harrow
Harrow < href='https://www.cnbc.com/stock/HRWRF' target='_blank'>Harrow has been making waves in the market as the IBD Stock Of The Day, and for good reason. This company has been consistently delivering impressive earnings growth and has a strong track record of innovation. With its sights set on a breakout, Harrow is an attractive option for investors looking to capitalize on its potential.
<3>The Technicals Are Looking Good
From a technical standpoint, Harrow’s stock has been showing signs of strength. The company’s Relative Strength Line has been trending upwards, indicating a strong performance compared to the S&P 500. Additionally, the stock’s 14-day RSI is currently at 70, which is a neutral reading, but it’s worth noting that the stock has been in an uptrend for the past few weeks.
<3>The Fundamental Analysis
Fundamentally, Harrow has a strong balance sheet, with a current ratio of 2.5 and a debt-to-equity ratio of 0.2. This suggests that the company has a solid